ENV
0.003
50%
LUX
0.225
-32.8%
DAL
0.105
40%
NGX
0.051
-27.1%
ARO
0.004
33.3%
LIB
0.003
-25%
EDE
0.083
27.7%
EGR
0.225
-22.4%
GLL
0.005
25%
FEL
0.004
-20%
BOA
0.19
22.6%
SRJ
0.004
-20%
CMO
0.006
20%
EXR
0.062
-18.4%
SEA
1.855
18.5%
IBX
0.006
-14.3%
KZR
0.165
17.9%
PNT
0.006
-14.3%
FMN
0.14
16.7%
NOV
0.014
-12.5%
AUV
0.008
14.3%
SKS
9.78
-12.4%
CXZ
0.025
13.6%
A4N
0.582
-11.8%
AEU
0.405
12.5%
AON
0.053
-11.7%
CMD
0.018
12.5%
ERL
0.008
-11.1%
FAU
0.18
12.5%
KRM
0.019
-9.5%
MHC
0.018
12.5%
IIQ
0.155
-8.8%
GAS
0.01
11.1%
ECT
0.105
-8.7%
MLS
0.02
11.1%
LSA
0.105
-8.7%
BKT
0.011
10%
AR1
0.069
-8%
PKO
0.011
10%
JNS
0.68
-7.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CMP FDA clearance

Compumedics (ASX:CMP) announces the US FDA has cleared the Somfit device to be marketed in the USA. This marks the achievement of another significant strategic milestone for the Somfit technology platform in one of the world’s largest sleep markets https://www.compumedics.com.au/en/asx-announcements/somfit-update2-2/ #shorts